Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle Modification

Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle Modification

Noninvasive risk stratification is a challenging issue in the management of patients with nonalcoholic fatty liver disease (NAFLD). This study aimed to identify multiomics-based predictors of NAFLD progression, as assessed by changes in serial FibroScan-aspartate aminotransferase (FAST) scores durin...

Full description

Bibliographic Details
Main Authors:	Hwi Young Kim, Da Jung Kim, Hye Ah Lee, Joo-Youn Cho, Won Kim
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	Metabolites
Subjects:	steatosis steatohepatitis nonalcoholic steatohepatitis risk stratification prediction multiomics
Online Access:	https://www.mdpi.com/2218-1989/13/3/444

Similar Items

Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
by: Wasitha P. D. W. Thilakarathna, et al.
Published: (2024-02-01)

Hepatic PEMT Expression Decreases with Increasing NAFLD Severity
by: Ignazio S. Piras, et al.
Published: (2022-08-01)

The long‐term protective effects of neonatal administration of curcumin against nonalcoholic steatohepatitis in high‐fructose‐fed adolescent rats
by: Kasimu G. Ibrahim, et al.
Published: (2019-03-01)

An open-label randomized control study to compare the efficacy of vitamin e versus ursodeoxycholic acid in nondiabetic and noncirrhotic Indian NAFLD patients
by: Pathik Parikh, et al.
Published: (2016-01-01)

SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate CellsSummary
by: Xiaolin Zhong, et al.
Published: (2020-01-01)

Metabolically associated fatty liver disease – a disease of the 21st century: A review
by: Igor V. Maev, et al.
Published: (2022-07-01)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in MiceSummary
by: Sadatsugu Sakane, et al.
Published: (2021-01-01)

The role of the microbiome in NAFLD and NASH
by: Aleksandra A Kolodziejczyk, et al.
Published: (2019-02-01)

ADEMETHIONINE IN THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: A. V. Polukhina, et al.
Published: (2017-11-01)

Prediction of course and progression of nonalcoholic fatty liver disease in patients with obesity and pathology of the biliary tract with the help of mathematical modeling.
by: A. Yu. Filippova, et al.
Published: (2017-12-01)

Therapeutic Mechanisms and Clinical Effects of Glucagon-like Peptide 1 Receptor Agonists in Nonalcoholic Fatty Liver Disease
by: Han Ah Lee, et al.
Published: (2023-05-01)

Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial
by: Han Ah Lee, et al.
Published: (2023-08-01)

Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
by: Stephen D. H. Malnick, et al.
Published: (2022-12-01)

Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
by: Gang Xu, et al.
Published: (2021-04-01)

Liver ultrasound scanning in the detection of hepatic steatosis and fibrosis in NASH patients
by: Mona Hegazy, et al.
Published: (2012-01-01)

Clinical and histological features of non-Alcoholic steatohepatitis in Iranian patients
by: "Ebrahimi Daryani N, et al.
Published: (2003-03-01)

Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in Obese Chinese
by: Jiarui Chen, et al.
Published: (2024-12-01)

Epidemiology and natural history of NAFLD
by: Della Corte Claudia, et al.
Published: (2015-01-01)

Artificial Intelligence in NAFLD: Will Liver Biopsy Still Be Necessary in the Future?
by: Lei Zhang, et al.
Published: (2022-12-01)

An Update on the Chemokine System in the Development of NAFLD
by: Naoto Nagata, et al.
Published: (2022-06-01)

Dietary and genetic disruption of hepatic methionine metabolism induce acid sphingomyelinase to promote steatohepatitis
by: Cristina Alarcón-Vila, et al.
Published: (2023-02-01)

Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis[S]
by: George N. Ioannou, et al.
Published: (2013-05-01)

CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease
by: Ha Neul Kim, et al.
Published: (2023-03-01)

Utility of human relevant preclinical animal models in navigating NAFLD to MAFLD paradigm
by: Chua, Damien, et al.
Published: (2023)

Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients
by: Haghpanah Babak, et al.
Published: (2003-10-01)

Multinodular fatty liver after herpes-zoster vaccine: Case report and review of the literature
by: Michael Shim, et al.
Published: (2008-10-01)

Noninvasive Diagnosis of NAFLD and NASH
by: Valeria Annarita Piazzolla, et al.
Published: (2020-04-01)

Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
by: Rodrigo Bremer Nones, et al.
Published: (2017-02-01)

Chemotherapy-associated steatohepatitis
by: Lucy Meunier, et al.
Published: (2020-11-01)

Icariin Supplementation Suppresses the Markers of Ferroptosis and Attenuates the Progression of Nonalcoholic Steatohepatitis in Mice Fed a Methionine Choline-Deficient Diet
by: Jiwon Choi, et al.
Published: (2023-08-01)

Possible Development of Burn-Out Nonalcoholic Steatohepatitis under Long-Term Steroid Use
by: Soichiro Ota, et al.
Published: (2022-09-01)

Clinical and pathogenetic differences of the course of flow nonalcoholic steatohepatitis in obese patients with and without hypertension
by: O.S. Khukhlina, et al.
Published: (2013-08-01)

Histological findings and NAFLD/NASH Status in liver biopsies of patients subjected to bariatric surgery
by: Marielle Malucelli, et al.
Published: (2023-11-01)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
by: A. V. Bogolyubova, et al.
Published: (2019-12-01)

Recent research trends and updates on nonalcoholic fatty liver disease
by: Jeong-Ju Yoo, et al.
Published: (2019-03-01)

Treatment Options in Non-alcoholic Fatty Liver Disease
by: Won Kim
Published: (2017-06-01)

Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis
by: Man Wang, et al.
Published: (2022-10-01)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
by: T. E. Promenasheva, et al.
Published: (2014-09-01)

Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease
by: Raptis DD, et al.
Published: (2023-01-01)

The significance of hepatic transaminases and ultrasound in the diagnosis of non-alcoholic fatty liver disease
by: Y. M. Stepanov, et al.
Published: (2018-03-01)